Published in:
01-03-2023 | COVID-19 | What's New In Intensive Care
Helmet trials: resolving the puzzle
Authors:
Yaseen M. Arabi, Bhakti K. Patel, Massimo Antonelli
Published in:
Intensive Care Medicine
|
Issue 4/2023
Login to get access
Excerpt
Helmet noninvasive ventilation has been used in patients with acute hypoxemic respiratory failure for over two decades, and its use has increased during the coronavirus disease 19 (COVID-19) pandemic [
1]. Compared with mask interface, the helmet interface has the advantage of delivering prolonged and uninterrupted treatment with higher levels of positive airway pressure [
2]. Additionally, helmet use, compared with mask interface, is associated with less air leak, lower risk for skin injury, and lower aerosol generation [
3,
4]. However, the use of helmet interface has not gained wide popularity because of the limited availability, increased cost, limited experience with its use, and the perceived intolerance of some patients to helmet interface due to claustrophobia. In this paper, we provide some insights into the differences in the design of three selected helmet trials to inform the interpretation of the findings [
5‐
7]. …